Report Cover

Global and United States Implantable Drug-Eluting Devices Market Insights, Forecast to 2027


Implantable Drug-Eluting Devices market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Implantable Drug-Eluting Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For United States market, this report focuses on the Implantable Drug-Eluting Devices market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in United States.

Segment by Type
    Implantable Drug Infusion Pumps
    Intraocular Drug-Eluting Devices
    Contraceptive Drug-Eluting Devices
    Drug-Eluting Stents
    Others

Segment by Application
    Diabetes
    Contraception
    HIV/AIDS Prevention
    Chronic Pain Management
    Cardiovascular
    Ophthalmology
    Oncology
    Others

By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Taiwan
        Indonesia
        Thailand
        Malaysia
        Philippines
        Vietnam
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        U.A.E

By Company
    Pfizer
    Medtronic
    Merck
    Bayer AG
    Johnson & Johnson
    Abbott
    Surmodics
    Boston Scientific Corporation
    Titan Pharmaceuticals, Inc.
    BIOTRONIK
    Allergan
    Bausch & Lomb
    REVA Medical
    MicroPort Medical
1 Study Coverage
    1.1 Implantable Drug-Eluting Devices Product Introduction
    1.2 Market by Type
        1.2.1 Global Implantable Drug-Eluting Devices Market Size Growth Rate by Type
        1.2.2 Implantable Drug Infusion Pumps
        1.2.3 Intraocular Drug-Eluting Devices
        1.2.4 Contraceptive Drug-Eluting Devices
        1.2.5 Drug-Eluting Stents
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Implantable Drug-Eluting Devices Market Size Growth Rate by Application
        1.3.2 Diabetes
        1.3.3 Contraception
        1.3.4 HIV/AIDS Prevention
        1.3.5 Chronic Pain Management
        1.3.6 Cardiovascular
        1.3.7 Ophthalmology
        1.3.8 Oncology
        1.3.9 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Executive Summary
    2.1 Global Implantable Drug-Eluting Devices Market Size, Estimates and Forecasts
        2.1.1 Global Implantable Drug-Eluting Devices Revenue 2016-2027
        2.1.2 Global Implantable Drug-Eluting Devices Sales 2016-2027
    2.2 Global Implantable Drug-Eluting Devices, Market Size by Region: 2016 VS 2021 VS 2027
    2.3 Implantable Drug-Eluting Devices Historical Market Size by Region (2016-2021)
        2.3.1 Global Implantable Drug-Eluting Devices Retrospective Market Scenario in Sales by Region: 2016-2021
        2.3.2 Global Implantable Drug-Eluting Devices Retrospective Market Scenario in Revenue by Region: 2016-2021
    2.4 Implantable Drug-Eluting Devices Market Estimates and Projections by Region (2022-2027)
        2.4.1 Global Implantable Drug-Eluting Devices Sales Forecast by Region (2022-2027)
        2.4.2 Global Implantable Drug-Eluting Devices Revenue Forecast by Region (2022-2027)

3 Global Implantable Drug-Eluting Devices Competitor Landscape by Players
    3.1 Global Top Implantable Drug-Eluting Devices Manufacturers by Sales
        3.1.1 Global Implantable Drug-Eluting Devices Sales by Manufacturer (2016-2021)
        3.1.2 Global Implantable Drug-Eluting Devices Sales Market Share by Manufacturer (2016-2021)
    3.2 Global Top Implantable Drug-Eluting Devices Manufacturers by Revenue
        3.2.1 Key Implantable Drug-Eluting Devices Manufacturers Covered: Ranking by Revenue
        3.2.2 Global Implantable Drug-Eluting Devices Revenue by Manufacturers (2016-2021)
        3.2.3 Global Implantable Drug-Eluting Devices Revenue Share by Manufacturers (2016-2021)
        3.2.4 Global Implantable Drug-Eluting Devices Market Concentration Ratio (CR5 and HHI) (2016-2021)
        3.2.5 Global Top 10 and Top 5 Companies by Implantable Drug-Eluting Devices Revenue in 2020
        3.2.6 Global Implantable Drug-Eluting Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Global Implantable Drug-Eluting Devices Price by Manufacturers
    3.4 Global Implantable Drug-Eluting Devices Manufacturing Base Distribution, Product Types
        3.4.1 Implantable Drug-Eluting Devices Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Implantable Drug-Eluting Devices Product Type
        3.4.3 Date of International Manufacturers Enter into Implantable Drug-Eluting Devices Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
    4.1 Global Implantable Drug-Eluting Devices Market Size by Type (2016-2021)
        4.1.1 Global Implantable Drug-Eluting Devices Sales by Type (2016-2021)
        4.1.2 Global Implantable Drug-Eluting Devices Revenue by Type (2016-2021)
        4.1.3 Implantable Drug-Eluting Devices Average Selling Price (ASP) by Type (2016-2021)
    4.2 Global Implantable Drug-Eluting Devices Market Size Forecast by Type (2022-2027)
        4.2.1 Global Implantable Drug-Eluting Devices Sales Forecast by Type (2022-2027)
        4.2.2 Global Implantable Drug-Eluting Devices Revenue Forecast by Type (2022-2027)
        4.2.3 Implantable Drug-Eluting Devices Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
    5.1 Global Implantable Drug-Eluting Devices Market Size by Application (2016-2021)
        5.1.1 Global Implantable Drug-Eluting Devices Sales by Application (2016-2021)
        5.1.2 Global Implantable Drug-Eluting Devices Revenue by Application (2016-2021)
        5.1.3 Implantable Drug-Eluting Devices Price by Application (2016-2021)
    5.2 Implantable Drug-Eluting Devices Market Size Forecast by Application (2022-2027)
        5.2.1 Global Implantable Drug-Eluting Devices Sales Forecast by Application (2022-2027)
        5.2.2 Global Implantable Drug-Eluting Devices Revenue Forecast by Application (2022-2027)
        5.2.3 Global Implantable Drug-Eluting Devices Price Forecast by Application (2022-2027)

6 United States by Players, Type and Application
    6.1 United States Implantable Drug-Eluting Devices Market Size YoY Growth 2016-2027
        6.1.1 United States Implantable Drug-Eluting Devices Sales YoY Growth 2016-2027
        6.1.2 United States Implantable Drug-Eluting Devices Revenue YoY Growth 2016-2027
        6.1.3 United States Implantable Drug-Eluting Devices Market Share in Global Market 2016-2027
    6.2 United States Implantable Drug-Eluting Devices Market Size by Players (International and Local Players)
        6.2.1 United States Top Implantable Drug-Eluting Devices Players by Sales (2016-2021)
        6.2.2 United States Top Implantable Drug-Eluting Devices Players by Revenue (2016-2021)
    6.3 United States Implantable Drug-Eluting Devices Historic Market Review by Type (2016-2021)
        6.3.1 United States Implantable Drug-Eluting Devices Sales Market Share by Type (2016-2021)
        6.3.2 United States Implantable Drug-Eluting Devices Revenue Market Share by Type (2016-2021)
        6.3.3 United States Implantable Drug-Eluting Devices Price by Type (2016-2021)
    6.4 United States Implantable Drug-Eluting Devices Market Estimates and Forecasts by Type (2022-2027)
        6.4.1 United States Implantable Drug-Eluting Devices Sales Forecast by Type (2022-2027)
        6.4.2 United States Implantable Drug-Eluting Devices Revenue Forecast by Type (2022-2027)
        6.4.3 United States Implantable Drug-Eluting Devices Price Forecast by Type (2022-2027)
    6.5 United States Implantable Drug-Eluting Devices Historic Market Review by Application (2016-2021)
        6.5.1 United States Implantable Drug-Eluting Devices Sales Market Share by Application (2016-2021)
        6.5.2 United States Implantable Drug-Eluting Devices Revenue Market Share by Application (2016-2021)
        6.5.3 United States Implantable Drug-Eluting Devices Price by Application (2016-2021)
    6.6 United States Implantable Drug-Eluting Devices Market Estimates and Forecasts by Application (2022-2027)
        6.6.1 United States Implantable Drug-Eluting Devices Sales Forecast by Application (2022-2027)
        6.6.2 United States Implantable Drug-Eluting Devices Revenue Forecast by Application (2022-2027)
        6.6.3 United States Implantable Drug-Eluting Devices Price Forecast by Application (2022-2027)

7 North America
    7.1 North America Implantable Drug-Eluting Devices Market Size YoY Growth 2016-2027
    7.2 North America Implantable Drug-Eluting Devices Market Facts & Figures by Country
        7.2.1 North America Implantable Drug-Eluting Devices Sales by Country (2016-2021)
        7.2.2 North America Implantable Drug-Eluting Devices Revenue by Country (2016-2021)
        7.2.3 U.S.
        7.2.4 Canada

8 Asia Pacific
    8.1 Asia Pacific Implantable Drug-Eluting Devices Market Size YoY Growth 2016-2027
    8.2 Asia Pacific Implantable Drug-Eluting Devices Market Facts & Figures by Region
        8.2.1 Asia Pacific Implantable Drug-Eluting Devices Sales by Region (2016-2021)
        8.2.2 Asia Pacific Implantable Drug-Eluting Devices Revenue by Region (2016-2021)
        8.2.3 China
        8.2.4 Japan
        8.2.5 South Korea
        8.2.6 India
        8.2.7 Australia
        8.2.8 Australia
        8.2.9 Indonesia
        8.2.10 Thailand
        8.2.11 Malaysia
        8.2.12 Philippines
        8.2.13 Vietnam

9 Europe
    9.1 Europe Implantable Drug-Eluting Devices Market Size YoY Growth 2016-2027
    9.2 Europe Implantable Drug-Eluting Devices Market Facts & Figures by Country
        9.2.1 Europe Implantable Drug-Eluting Devices Sales by Country (2016-2021)
        9.2.2 Europe Implantable Drug-Eluting Devices Revenue by Country (2016-2021)
        9.2.3 Germany
        9.2.4 France
        9.2.5 U.K.
        9.2.6 Italy

10 Latin America
    10.1 Latin America Implantable Drug-Eluting Devices Market Size YoY Growth 2016-2027
    10.2 Latin America Implantable Drug-Eluting Devices Market Facts & Figures by Country
        10.2.1 Latin America Implantable Drug-Eluting Devices Sales by Country (2016-2021)
        10.2.2 Latin America Implantable Drug-Eluting Devices Revenue by Country (2016-2021)
        10.2.3 Mexico
        10.2.4 Brazil
        10.2.5 Argentina

11 Middle East and Africa
    11.1 Middle East and Africa Implantable Drug-Eluting Devices Market Size YoY Growth 2016-2027
    11.2 Middle East and Africa Implantable Drug-Eluting Devices Market Facts & Figures by Country
        11.2.1 Middle East and Africa Implantable Drug-Eluting Devices Sales by Country (2016-2021)
        11.2.2 Middle East and Africa Implantable Drug-Eluting Devices Revenue by Country (2016-2021)
        11.2.3 Turkey
        11.2.4 Saudi Arabia
        11.2.5 U.A.E

12 Company Profiles
    12.1 Pfizer
        12.1.1 Pfizer Corporation Information
        12.1.2 Pfizer Description and Business Overview
        12.1.3 Pfizer Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
        12.1.4 Pfizer Implantable Drug-Eluting Devices Products Offered
        12.1.5 Pfizer Recent Development
    12.2 Medtronic
        12.2.1 Medtronic Corporation Information
        12.2.2 Medtronic Description and Business Overview
        12.2.3 Medtronic Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
        12.2.4 Medtronic Implantable Drug-Eluting Devices Products Offered
        12.2.5 Medtronic Recent Development
    12.3 Merck
        12.3.1 Merck Corporation Information
        12.3.2 Merck Description and Business Overview
        12.3.3 Merck Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
        12.3.4 Merck Implantable Drug-Eluting Devices Products Offered
        12.3.5 Merck Recent Development
    12.4 Bayer AG
        12.4.1 Bayer AG Corporation Information
        12.4.2 Bayer AG Description and Business Overview
        12.4.3 Bayer AG Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
        12.4.4 Bayer AG Implantable Drug-Eluting Devices Products Offered
        12.4.5 Bayer AG Recent Development
    12.5 Johnson & Johnson
        12.5.1 Johnson & Johnson Corporation Information
        12.5.2 Johnson & Johnson Description and Business Overview
        12.5.3 Johnson & Johnson Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
        12.5.4 Johnson & Johnson Implantable Drug-Eluting Devices Products Offered
        12.5.5 Johnson & Johnson Recent Development
    12.6 Abbott
        12.6.1 Abbott Corporation Information
        12.6.2 Abbott Description and Business Overview
        12.6.3 Abbott Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
        12.6.4 Abbott Implantable Drug-Eluting Devices Products Offered
        12.6.5 Abbott Recent Development
    12.7 Surmodics
        12.7.1 Surmodics Corporation Information
        12.7.2 Surmodics Description and Business Overview
        12.7.3 Surmodics Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
        12.7.4 Surmodics Implantable Drug-Eluting Devices Products Offered
        12.7.5 Surmodics Recent Development
    12.8 Boston Scientific Corporation
        12.8.1 Boston Scientific Corporation Corporation Information
        12.8.2 Boston Scientific Corporation Description and Business Overview
        12.8.3 Boston Scientific Corporation Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
        12.8.4 Boston Scientific Corporation Implantable Drug-Eluting Devices Products Offered
        12.8.5 Boston Scientific Corporation Recent Development
    12.9 Titan Pharmaceuticals, Inc.
        12.9.1 Titan Pharmaceuticals, Inc. Corporation Information
        12.9.2 Titan Pharmaceuticals, Inc. Description and Business Overview
        12.9.3 Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
        12.9.4 Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Products Offered
        12.9.5 Titan Pharmaceuticals, Inc. Recent Development
    12.10 BIOTRONIK
        12.10.1 BIOTRONIK Corporation Information
        12.10.2 BIOTRONIK Description and Business Overview
        12.10.3 BIOTRONIK Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
        12.10.4 BIOTRONIK Implantable Drug-Eluting Devices Products Offered
        12.10.5 BIOTRONIK Recent Development
    12.11 Pfizer
        12.11.1 Pfizer Corporation Information
        12.11.2 Pfizer Description and Business Overview
        12.11.3 Pfizer Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
        12.11.4 Pfizer Implantable Drug-Eluting Devices Products Offered
        12.11.5 Pfizer Recent Development
    12.12 Bausch & Lomb
        12.12.1 Bausch & Lomb Corporation Information
        12.12.2 Bausch & Lomb Description and Business Overview
        12.12.3 Bausch & Lomb Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
        12.12.4 Bausch & Lomb Products Offered
        12.12.5 Bausch & Lomb Recent Development
    12.13 REVA Medical
        12.13.1 REVA Medical Corporation Information
        12.13.2 REVA Medical Description and Business Overview
        12.13.3 REVA Medical Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
        12.13.4 REVA Medical Products Offered
        12.13.5 REVA Medical Recent Development
    12.14 MicroPort Medical
        12.14.1 MicroPort Medical Corporation Information
        12.14.2 MicroPort Medical Description and Business Overview
        12.14.3 MicroPort Medical Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
        12.14.4 MicroPort Medical Products Offered
        12.14.5 MicroPort Medical Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Implantable Drug-Eluting Devices Industry Trends
    13.2 Implantable Drug-Eluting Devices Market Drivers
    13.3 Implantable Drug-Eluting Devices Market Challenges
    13.4 Implantable Drug-Eluting Devices Market Restraints

14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 Implantable Drug-Eluting Devices Customers
    14.3 Sales Channels Analysis
        14.3.1 Sales Channels
        14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer

List of Tables Table 1. Global Implantable Drug-Eluting Devices Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Implantable Drug Infusion Pumps Table 3. Major Manufacturers of Intraocular Drug-Eluting Devices Table 4. Major Manufacturers of Contraceptive Drug-Eluting Devices Table 5. Major Manufacturers of Drug-Eluting Stents Table 6. Major Manufacturers of Others Table 7. Global Implantable Drug-Eluting Devices Market Size Growth Rate by Application (2021-2027) & (K Units) Table 8. Global Implantable Drug-Eluting Devices Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027 Table 9. Global Implantable Drug-Eluting Devices Sales by Regions (2016-2021) & (K Units) Table 10. Global Implantable Drug-Eluting Devices Sales Market Share by Regions (2016-2021) Table 11. Global Implantable Drug-Eluting Devices Revenue by Regions (2016-2021) & (US$ Million) Table 12. Global Implantable Drug-Eluting Devices Sales Forecast by Region (2022-2027) & (K Units) Table 13. Global Implantable Drug-Eluting Devices Sales Market Share Forecast by Region (2022-2027) Table 14. Global Implantable Drug-Eluting Devices Revenue Forecast by Region (2022-2027) & (US$ Million) Table 15. Global Implantable Drug-Eluting Devices Revenue Market Share Forecast by Region (2022-2027) Table 16. Global Implantable Drug-Eluting Devices Sales by Manufacturers (2016-2021) (K Units) Table 17. Global Implantable Drug-Eluting Devices Sales Share by Manufacturers (2016-2021) Table 18. Ranking of Global Top Implantable Drug-Eluting Devices Manufacturers by Revenue (US$ Million) in 2020 Table 19. Implantable Drug-Eluting Devices Revenue by Manufacturers (2016-2021) (US$ Million) Table 20. Implantable Drug-Eluting Devices Revenue Share by Manufacturers (2016-2021) Table 21. Global Implantable Drug-Eluting Devices Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 22. Global Implantable Drug-Eluting Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Implantable Drug-Eluting Devices as of 2020) Table 23. Key Manufacturers Implantable Drug-Eluting Devices Price (2016-2021) (USD/Unit) Table 24. Implantable Drug-Eluting Devices Manufacturers Manufacturing Base Distribution and Headquarters Table 25. Manufacturers Implantable Drug-Eluting Devices Product Type Table 26. Date of International Manufacturers Enter into Implantable Drug-Eluting Devices Market Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans Table 28. Global Implantable Drug-Eluting Devices Sales by Type (2016-2021) (K Units) Table 29. Global Implantable Drug-Eluting Devices Sales Share by Type (2016-2021) Table 30. Global Implantable Drug-Eluting Devices Revenue by Type (2016-2021) (US$ Million) Table 31. Global Implantable Drug-Eluting Devices Revenue Share by Type (2016-2021) Table 32. Implantable Drug-Eluting Devices Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit) Table 33. Global Implantable Drug-Eluting Devices Sales Forecast by Type (2022-2027) & (K Units) Table 34. Global Implantable Drug-Eluting Devices Sales Market Share Forecast by Type (2022-2027) Table 35. Global Implantable Drug-Eluting Devices Revenue Forecast V (2022-2027) & (US$ Million) Table 36. Global Implantable Drug-Eluting Devices Revenue Market Share Forecast by Type (2022-2027) Table 37. Global Implantable Drug-Eluting Devices Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit) Table 38. Global Implantable Drug-Eluting Devices Sales by Application (2016-2021) (K Units) Table 39. Global Implantable Drug-Eluting Devices Sales Share by Application (2016-2021) Table 40. Global Implantable Drug-Eluting Devices Revenue by Application (2016-2021) (US$ Million) Table 41. Global Implantable Drug-Eluting Devices Revenue Share by Application (2016-2021) Table 42. Implantable Drug-Eluting Devices Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit) Table 43. Global Implantable Drug-Eluting Devices Sales Forecast by Application (2022-2027) & (K Units) Table 44. Global Implantable Drug-Eluting Devices Sales Market Share Forecast by Application (2022-2027) Table 45. Global Implantable Drug-Eluting Devices Revenue Forecast by Application (2022-2027) & (US$ Million) Table 46. Global Implantable Drug-Eluting Devices Revenue Market Share Forecast by Application (2022-2027) Table 47. Global Implantable Drug-Eluting Devices Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit) Table 48. United States Implantable Drug-Eluting Devices Sales (K Units) of Key Companies (2016-2021) Table 49. United States Implantable Drug-Eluting Devices Sales Share by Company (2016-2021) Table 50. United States Implantable Drug-Eluting Devices Revenue (US$ Million) by Company (2016-2021) Table 51. United States Implantable Drug-Eluting Devices Revenue Share by Company (2016-2021) Table 52. United States Implantable Drug-Eluting Devices Sales (K Units) by Type (2016-2021) Table 53. United States Implantable Drug-Eluting Devices Sales Share by Type (2016-2021) Table 54. United States Implantable Drug-Eluting Devices Revenue (US$ Million) Market Share by Type (2016-2021) Table 55. United States Implantable Drug-Eluting Devices Price (USD/Unit) by Type (2016-2021) Table 56. United States Implantable Drug-Eluting Devices Sales (K Units) by Type (2022-2027) Table 57. United States Implantable Drug-Eluting Devices Sales Share by Type (2022-2027) Table 58. United States Implantable Drug-Eluting Devices Revenue (US$ Million) Market Share by Type (2022-2027) Table 59. United States Implantable Drug-Eluting Devices Revenue Share by Type (2022-2027) Table 60. United States Implantable Drug-Eluting Devices Price (USD/Unit) by Type (2022-2027) Table 61. United States Implantable Drug-Eluting Devices Sales (K Units) by Application (2016-2021) Table 62. United States Implantable Drug-Eluting Devices Sales Share by Application (2016-2021) Table 63. United States Implantable Drug-Eluting Devices Revenue (US$ Million) Market Share by Application (2016-2021) Table 64. United States Implantable Drug-Eluting Devices Price (USD/Unit) by Application (2016-2021) Table 65. United States Implantable Drug-Eluting Devices Sales (K Units) by Application (2022-2027) Table 66. United States Implantable Drug-Eluting Devices Sales Share by Application (2022-2027) Table 67. United States Implantable Drug-Eluting Devices Revenue (US$ Million) Market Share by Application (2022-2027) Table 68. United States Implantable Drug-Eluting Devices Revenue Share by Application (2022-2027) Table 69. United States Implantable Drug-Eluting Devices Price (USD/Unit) by Application (2022-2027) Table 70. North America Implantable Drug-Eluting Devices Sales by Country (2016-2021) & (K Units) Table 71. North America Implantable Drug-Eluting Devices Sales Market Share by Country (2016-2021) Table 72. North America Implantable Drug-Eluting Devices Revenue by Country (2016-2021) & (US$ Million) Table 73. North America Implantable Drug-Eluting Devices Revenue Market Share by Country (2016-2021) Table 74. Asia Pacific Implantable Drug-Eluting Devices Sales by Region (2016-2021) & (K Units) Table 75. Asia Pacific Implantable Drug-Eluting Devices Sales Market Share by Region (2016-2021) Table 76. Asia Pacific Implantable Drug-Eluting Devices Revenue by Region (2016-2021) & (US$ Million) Table 77. Asia Pacific Implantable Drug-Eluting Devices Revenue Market Share by Region (2016-2021) Table 78. Europe Implantable Drug-Eluting Devices Sales by Country (2016-2021) & (K Units) Table 79. Europe Implantable Drug-Eluting Devices Sales Market Share by Country (2016-2021) Table 80. Europe Implantable Drug-Eluting Devices Revenue by Country (2016-2021) & (US$ Million) Table 81. Europe Implantable Drug-Eluting Devices Revenue Market Share by Country (2016-2021) Table 82. Latin America Implantable Drug-Eluting Devices Sales by Country (2016-2021) & (K Units) Table 83. Latin America Implantable Drug-Eluting Devices Sales Market Share by Country (2016-2021) Table 84. Latin Americaa Implantable Drug-Eluting Devices Revenue by Country (2016-2021) & (US$ Million) Table 85. Latin America Implantable Drug-Eluting Devices Revenue Market Share by Country (2016-2021) Table 86. Middle East and Africa Implantable Drug-Eluting Devices Sales by Country (2016-2021) & (K Units) Table 87. Middle East and Africa Implantable Drug-Eluting Devices Sales Market Share by Country (2016-2021) Table 88. Middle East and Africa Implantable Drug-Eluting Devices Revenue by Country (2016-2021) & (US$ Million) Table 89. Middle East and Africa Implantable Drug-Eluting Devices Revenue Market Share by Country (2016-2021) Table 90. Pfizer Corporation Information Table 91. Pfizer Description and Business Overview Table 92. Pfizer Implantable Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 93. Pfizer Implantable Drug-Eluting Devices Product Table 94. Pfizer Recent Development Table 95. Medtronic Corporation Information Table 96. Medtronic Description and Business Overview Table 97. Medtronic Implantable Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 98. Medtronic Product Table 99. Medtronic Recent Development Table 100. Merck Corporation Information Table 101. Merck Description and Business Overview Table 102. Merck Implantable Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 103. Merck Product Table 104. Merck Recent Development Table 105. Bayer AG Corporation Information Table 106. Bayer AG Description and Business Overview Table 107. Bayer AG Implantable Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 108. Bayer AG Product Table 109. Bayer AG Recent Development Table 110. Johnson & Johnson Corporation Information Table 111. Johnson & Johnson Description and Business Overview Table 112. Johnson & Johnson Implantable Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 113. Johnson & Johnson Product Table 114. Johnson & Johnson Recent Development Table 115. Abbott Corporation Information Table 116. Abbott Description and Business Overview Table 117. Abbott Implantable Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 118. Abbott Product Table 119. Abbott Recent Development Table 120. Surmodics Corporation Information Table 121. Surmodics Description and Business Overview Table 122. Surmodics Implantable Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 123. Surmodics Product Table 124. Surmodics Recent Development Table 125. Boston Scientific Corporation Corporation Information Table 126. Boston Scientific Corporation Description and Business Overview Table 127. Boston Scientific Corporation Implantable Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 128. Boston Scientific Corporation Product Table 129. Boston Scientific Corporation Recent Development Table 130. Titan Pharmaceuticals, Inc. Corporation Information Table 131. Titan Pharmaceuticals, Inc. Description and Business Overview Table 132. Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 133. Titan Pharmaceuticals, Inc. Product Table 134. Titan Pharmaceuticals, Inc. Recent Development Table 135. BIOTRONIK Corporation Information Table 136. BIOTRONIK Description and Business Overview Table 137. BIOTRONIK Implantable Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 138. BIOTRONIK Product Table 139. BIOTRONIK Recent Development Table 140. Allergan Corporation Information Table 141. Allergan Description and Business Overview Table 142. Allergan Implantable Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 143. Allergan Product Table 144. Allergan Recent Development Table 145. Bausch & Lomb Corporation Information Table 146. Bausch & Lomb Description and Business Overview Table 147. Bausch & Lomb Implantable Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 148. Bausch & Lomb Product Table 149. Bausch & Lomb Recent Development Table 150. REVA Medical Corporation Information Table 151. REVA Medical Description and Business Overview Table 152. REVA Medical Implantable Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 153. REVA Medical Product Table 154. REVA Medical Recent Development Table 155. MicroPort Medical Corporation Information Table 156. MicroPort Medical Description and Business Overview Table 157. MicroPort Medical Implantable Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 158. MicroPort Medical Product Table 159. MicroPort Medical Recent Development Table 160. Implantable Drug-Eluting Devices Market Trends Table 161. Implantable Drug-Eluting Devices Market Drivers Table 162. Implantable Drug-Eluting Devices Market Challenges Table 163. Implantable Drug-Eluting Devices Market Restraints Table 164. Implantable Drug-Eluting Devices Customers List Table 165. Implantable Drug-Eluting Devices Distributors List Table 166. Research Programs/Design for This Report Table 167. Key Data Information from Secondary Sources Table 168. Key Data Information from Primary Sources List of Figures Figure 1. Implantable Drug-Eluting Devices Product Picture Figure 2. Global Implantable Drug-Eluting Devices Sales Market Share by Type in 2020 & 2027 Figure 3. Implantable Drug Infusion Pumps Product Picture Figure 4. Intraocular Drug-Eluting Devices Product Picture Figure 5. Contraceptive Drug-Eluting Devices Product Picture Figure 6. Drug-Eluting Stents Product Picture Figure 7. Others Product Picture Figure 8. Global Implantable Drug-Eluting Devices Sales Market Share by Application in 2020 & 2027 Figure 9. Diabetes Figure 10. Contraception Figure 11. HIV/AIDS Prevention Figure 12. Chronic Pain Management Figure 13. Cardiovascular Figure 14. Ophthalmology Figure 15. Oncology Figure 16. Others Figure 17. Implantable Drug-Eluting Devices Report Years Considered Figure 18. Global Implantable Drug-Eluting Devices Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 19. Global Implantable Drug-Eluting Devices Market Size 2016-2027 (US$ Million) Figure 20. Global Implantable Drug-Eluting Devices Sales 2016-2027 (K Units) Figure 21. Global Implantable Drug-Eluting Devices Market Size Market Share by Region: 2021 Versus 2027 Figure 22. Global Implantable Drug-Eluting Devices Sales Market Share by Region (2016-2021) Figure 23. Global Implantable Drug-Eluting Devices Sales Market Share by Region in 2020 Figure 24. Global Implantable Drug-Eluting Devices Revenue Market Share by Region (2016-2021) Figure 25. Global Implantable Drug-Eluting Devices Revenue Market Share by Region in 2020 Figure 26. Global Implantable Drug-Eluting Devices Sales Share by Manufacturer in 2020 Figure 27. The Top 10 and 5 Players Market Share by Implantable Drug-Eluting Devices Revenue in 2020 Figure 28. Implantable Drug-Eluting Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 29. Global Implantable Drug-Eluting Devices Sales Market Share by Type (2016-2021) Figure 30. Global Implantable Drug-Eluting Devices Sales Market Share by Type in 2020 Figure 31. Global Implantable Drug-Eluting Devices Revenue Market Share by Type (2016-2021) Figure 32. Global Implantable Drug-Eluting Devices Revenue Market Share by Type in 2020 Figure 33. Global Implantable Drug-Eluting Devices Sales Market Share by Application (2016-2021) Figure 34. Global Implantable Drug-Eluting Devices Sales Market Share by Application in 2020 Figure 35. Global Implantable Drug-Eluting Devices Revenue Market Share by Application (2016-2021) Figure 36. Global Implantable Drug-Eluting Devices Revenue Market Share by Application in 2020 Figure 37. United States Implantable Drug-Eluting Devices Sales Growth Rate 2016-2027 (K Units) Figure 38. United States Implantable Drug-Eluting Devices Revenue Growth Rate 2016-2027 (US$ Million) Figure 39. United States Implantable Drug-Eluting Devices Market Share in Global Market 2016-2027 Figure 40. United States 5 and 10 Largest Implantable Drug-Eluting Devices Players Market Share by Revenue in Implantable Drug-Eluting Devices in 2020 Figure 41. United States Implantable Drug-Eluting Devices Revenue Share by Type (2016-2021) Figure 42. United States Implantable Drug-Eluting Devices Revenue Growth Rate by Type in 2016 & 2020 Figure 43. United States Implantable Drug-Eluting Devices Revenue Share by Application (2016-2021) Figure 44. United States Implantable Drug-Eluting Devices Revenue Growth Rate by Application in 2016 & 2020 Figure 45. North America Implantable Drug-Eluting Devices Sales Growth Rate 2016-2021 (K Units) Figure 46. North America Implantable Drug-Eluting Devices Revenue Growth Rate 2016-2021 (US$ Million) Figure 47. North America Implantable Drug-Eluting Devices Sales Market Share by Country in 2020 Figure 48. North America Implantable Drug-Eluting Devices Revenue Market Share by Country in 2020 Figure 49. U.S. Implantable Drug-Eluting Devices Sales Growth Rate (2016-2021) (K Units) Figure 50. U.S. Implantable Drug-Eluting Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 51. Canada Implantable Drug-Eluting Devices Sales Growth Rate (2016-2021) (K Units) Figure 52. Canada Implantable Drug-Eluting Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 53. Europe Implantable Drug-Eluting Devices Sales Growth Rate 2016-2021 (K Units) Figure 54. Europe Implantable Drug-Eluting Devices Revenue Growth Rate 2016-2021 (US$ Million) Figure 55. Europe Implantable Drug-Eluting Devices Sales Market Share by Country in 2020 Figure 56. Europe Implantable Drug-Eluting Devices Revenue Market Share by Country in 2020 Figure 57. Germany Implantable Drug-Eluting Devices Sales Growth Rate (2016-2021) (K Units) Figure 58. Germany Implantable Drug-Eluting Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 59. France Implantable Drug-Eluting Devices Sales Growth Rate (2016-2021) (K Units) Figure 60. France Implantable Drug-Eluting Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 61. U.K. Implantable Drug-Eluting Devices Sales Growth Rate (2016-2021) (K Units) Figure 62. U.K. Implantable Drug-Eluting Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 63. Italy Implantable Drug-Eluting Devices Sales Growth Rate (2016-2021) (K Units) Figure 64. Italy Implantable Drug-Eluting Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 65. Russia Implantable Drug-Eluting Devices Sales Growth Rate (2016-2021) (K Units) Figure 66. Russia Implantable Drug-Eluting Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 67. Asia Pacific Implantable Drug-Eluting Devices Sales Growth Rate 2016-2021 (K Units) Figure 68. Asia Pacific Implantable Drug-Eluting Devices Revenue Growth Rate 2016-2021 (US$ Million) Figure 69. Asia Pacific Implantable Drug-Eluting Devices Sales Market Share by Region in 2020 Figure 70. Asia Pacific Implantable Drug-Eluting Devices Revenue Market Share by Region in 2020 Figure 71. China Implantable Drug-Eluting Devices Sales Growth Rate (2016-2021) (K Units) Figure 72. China Implantable Drug-Eluting Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 73. Japan Implantable Drug-Eluting Devices Sales Growth Rate (2016-2021) (K Units) Figure 74. Japan Implantable Drug-Eluting Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 75. South Korea Implantable Drug-Eluting Devices Sales Growth Rate (2016-2021) (K Units) Figure 76. South Korea Implantable Drug-Eluting Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 77. India Implantable Drug-Eluting Devices Sales Growth Rate (2016-2021) (K Units) Figure 78. India Implantable Drug-Eluting Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 79. Australia Implantable Drug-Eluting Devices Sales Growth Rate (2016-2021) (K Units) Figure 80. Australia Implantable Drug-Eluting Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 81. Taiwan Implantable Drug-Eluting Devices Sales Growth Rate (2016-2021) (K Units) Figure 82. Taiwan Implantable Drug-Eluting Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 83. Indonesia Implantable Drug-Eluting Devices Sales Growth Rate (2016-2021) (K Units) Figure 84. Indonesia Implantable Drug-Eluting Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 85. Thailand Implantable Drug-Eluting Devices Sales Growth Rate (2016-2021) (K Units) Figure 86. Thailand Implantable Drug-Eluting Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 87. Malaysia Implantable Drug-Eluting Devices Sales Growth Rate (2016-2021) (K Units) Figure 88. Malaysia Implantable Drug-Eluting Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 89. Philippines Implantable Drug-Eluting Devices Sales Growth Rate (2016-2021) (K Units) Figure 90. Philippines Implantable Drug-Eluting Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 91. Vietnam Implantable Drug-Eluting Devices Sales Growth Rate (2016-2021) (K Units) Figure 92. Vietnam Implantable Drug-Eluting Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 93. Latin America Implantable Drug-Eluting Devices Sales Growth Rate 2016-2021 (K Units) Figure 94. Latin America Implantable Drug-Eluting Devices Revenue Growth Rate 2016-2021 (US$ Million) Figure 95. Latin America Implantable Drug-Eluting Devices Sales Market Share by Country in 2020 Figure 96. Latin America Implantable Drug-Eluting Devices Revenue Market Share by Country in 2020 Figure 97. Mexico Implantable Drug-Eluting Devices Sales Growth Rate (2016-2021) (K Units) Figure 98. Mexico Implantable Drug-Eluting Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 99. Brazil Implantable Drug-Eluting Devices Sales Growth Rate (2016-2021) (K Units) Figure 100. Brazil Implantable Drug-Eluting Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 101. Argentina Implantable Drug-Eluting Devices Sales Growth Rate (2016-2021) (K Units) Figure 102. Argentina Implantable Drug-Eluting Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 103. Middle East and Africa Implantable Drug-Eluting Devices Sales Growth Rate 2016-2021 (K Units) Figure 104. Middle East and Africa Implantable Drug-Eluting Devices Revenue Growth Rate 2016-2021 (US$ Million) Figure 105. Middle East and Africa Implantable Drug-Eluting Devices Sales Market Share by Country in 2020 Figure 106. Middle East and Africa Implantable Drug-Eluting Devices Revenue Market Share by Country in 2020 Figure 107. Turkey Implantable Drug-Eluting Devices Sales Growth Rate (2016-2021) (K Units) Figure 108. Turkey Implantable Drug-Eluting Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 109. Saudi Arabia Implantable Drug-Eluting Devices Sales Growth Rate (2016-2021) (K Units) Figure 110. Saudi Arabia Implantable Drug-Eluting Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 111. U.A.E Implantable Drug-Eluting Devices Sales Growth Rate (2016-2021) (K Units) Figure 112. U.A.E Implantable Drug-Eluting Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 113. Implantable Drug-Eluting Devices Value Chain Figure 114. Channels of Distribution Figure 115. Distributors Profiles Figure 116. Bottom-up and Top-down Approaches for This Report Figure 117. Data Triangulation Figure 118. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us